EP2845604
Ný ónæmismeðferð gegn fjölmörgum æxlum, þar á meðal krabbameini í meltingarfærum og maga
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.3.2011EP published:
8.3.2017EP application number:
14184348.2
EP translation filed:
11.4.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
14.3.2031Expiry date:
14.3.2023
Title:
Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
Timeline
Today
15.3.2011EP application
8.3.2017EP Publication
11.4.2017Translation submitted
15.9.2017Registration published
14.3.2023Expires
Owner
Name:
immatics biotechnologies GmbHAddress:
Paul-Ehrlich-Strasse 15, 72076, Tübingen, DE
Inventor
Name:
Weinschenk, ToniAddress:
Aichwald, DE
Name:
Fritsche, JensAddress:
Tuebingen, DE
Name:
Walter, SteffenAddress:
Reutlingen, DE
Name:
Lewandrowski, PeterAddress:
Tuebingen-Hirschau, DE
Name:
Singh, HarpreetAddress:
Muenchen, DE
Agent
Name:
Boehmert & BoehmertAddress:
Pettenkoferstrasse 20-22, DE
Priority
Number:
315704 PDate:
19.3.2010Country:
US
Number:
201004551Date:
19.3.2010Country:
GB
Classification
Categories:
A61K 38/17, A61K 39/00, C07K 7/06, C07K 7/08, G01N 33/50, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 27.4.2017
Expires: 14.3.2018
Payer: Guðjón Styrkársson, hrl.
Number: 8
Paid: 19.3.2018
Expires: 14.3.2019
Payer: Guðjón Styrkársson, hrl.
Number: 9
Paid: 18.3.2019
Expires: 14.3.2020
Payer: Guðjón Styrkársson, hrl.
Number: 10
Paid: 19.3.2020
Expires: 14.3.2021
Payer: Patice ehf.
Number: 11
Paid: 18.3.2021
Expires: 14.3.2022
Payer: Patice ehf.
Number: 12
Paid: 17.3.2022
Expires: 14.3.2023
Payer: Patice ehf.